RANITIDINE CLASS ACTION

Register with Charney Lawyers PC

Home

Register

We recommend that you do not throw away any leftover Ranitidine pills. If possible, store them in a safe place for potential testing and proof of purchase.

Update: Update: On October 30, 2019, Health Canada announced that Ranbaxy Pharmaceuticals Canada Inc. is recalling all lots of its prescription ranitidine products from the Canadian market.

Update: Update: On October 25, 2019, Health Canada announced that Dominion Pharmacal, Laboratoire Riva Inc., Pharmascience Inc. and Vita Health Inc. are recalling all lots of their prescription and over-the-counter ranitidine products from the Canadian market.

Update: On October 18, 2019, Health Canada advised that additional prescription and over-the-counter ranitidine drugs, including Zantac, are being recalled by Sanofi Consumer Health Inc., Sivem Pharmaceuticals ULC and Teva Canada Limited because they may contain NDMA above acceptable levels.

Health Canada detects NDMA in Ranitidine products

An impurity, N-nitrosodimethylamine (NDMA), has been detected in Ranitidine products for sale in Canada. NDMA is a potential human carcinogen, which means that it could cause cancer with long-term exposure.

The active pharmaceutical ingredient Ranitidine is indicated for the treatment of stomach problems, ulcers, heartburn, and gastroesophageal reflux disease (GERD).  Ranitidine products are available in Canada as over-the-counter medication or by prescription.

On September 13, 2019, Health Canada issued a product information update advising that they are investigating the presence of NDMA in some Ranitidine drugs.

A further Health Canada report on September 17, 2019, advised that all lots of Ranitidine 150mg and 300mg tablets were being recalled by Sandoz Canada Inc., one of the leading manufacturers of the drug.

On September 25, 2019, Health Canada advised that four other companies: Apotex Inc., Pro Doc Limitee, Sanis Health Inc. and Sivem Pharmaceuticals ULC were also recalling their Ranitidine drugs due to the presence of NDMA.

Ranitidine class action lawsuit

The law firms of Charney Lawyers PC and Rice Harbut Elliot LLP have commenced a national class action on behalf of all persons in Canada who purchased or ingested one or more of the Ranitidine products for sale in Canada from January 1, 2010 to present.

The press release, dated October 11, 2019, stating that a proposed class action has been commenced with respect to the recall can be viewed here.

Recalls and safety alerts from Health Canada

Ranbaxy Pharmaceuticals Canada Inc. recalls prescription ranitidine products as a precaution; request to stop distribution remains in place while Health Canada continues to assess NDMA, Health Canada, updated October 30, 2019.

Sun Pharma Canada Inc. Ranitidine Product Recall (2019-10-29), Health Canada, updated October 30, 2019.

Vita Health Products Inc Ranitidine Product Recall (2019-10-24), Health Canada, updated October 28, 2019.

Laboratoire Riva Inc. Ranitidine Product Recall (2019-10-24), Health Canada, updated October 25, 2019.

Pharmascience Inc. Ranitidine Product Recall (2019-10-23), Health Canada, updated October 25, 2019.

Maximum Strength Acid Reducer Without Prescription (2019-10-23), Health Canada, updated October 25, 2019.

Sanofi Consumer Health Zantac Product Recall (2019-10-18), Health Canada, updated October 23, 2019.

Teva Canada Ranitidine Product Recall (2019-10-17), updated October 28, 2019.

Appotex Inc Ranitidine Product Recall (2019-09-24), Health Canada, updated September 26, 2019.

Sanis Health Inc. Ranitidine Product Recall (2019-09-24), Health Canada, updated September 26, 2019.

Pro Doc Limitee Ranitidine Product Recall (2019-09-24), Health Canada, updated September 25, 2019.

Sivem Pharmaceuticals ULC Ranitidine Product Recall (2019-09-24), Health Canada, updated September 25, 2019.

Sandoz Canada Ranitidine Product Recall (2019-09-17), Health Canada, updated September 18, 2019.

Health Canada assessing NDMA in Ranitidine, Health Canada, updated September 13, 2019.

Health Canada’s list of Ranitidine products being recalled in Canada at this time:

CompanyProduct Name/Active Pharmaceutical Ingredient (API)DINStrengthLotDate added
Apotex Inc.Acid Reducer (ranitidine) sold under the brand names Equate and Selection02296160150 mgAll lotsSeptember 25, 2019
Apotex Inc.Apo-Ranitidine Oral Solution0228083315 mg/mLAll lotsSeptember 25, 2019
Apotex Inc.Apo-Ranitidine Tablet 150mg00733059150 mgAll lotsSeptember 25, 2019
Apotex Inc.Apo-Ranitidine Tablet 300mg00733067300 mgAll lotsSeptember 25, 2019
Dominion PharmacalMaximum Strength Acid Reducer Without Prescription (ranitidine) sold under the brand name Personnelle02407523150 mgAll lotsOctober 25, 2019
Laboratoire Riva Inc.Riva-Ranitidine 15002247814150 mgAll lotsOctober 25, 2019
Laboratoire Riva Inc.Riva-Ranitidine 30002247815300 mgAll lotsOctober 25, 2019
Laboratoire Riva Inc.Acid Reducer (ranitidine) sold under the brand names Biomedic, Circle K and Option+0245246475 mgAll lotsOctober 25, 2019
Pharmascience Inc.PMS-Ranitidine 150 mg02242453150 mgAll lotsOctober 25, 2019
Pharmascience Inc.PMS-Ranitidine 300 mg02242454300 mgAll lotsOctober 25, 2019
Pharmascience Inc.Acid Reducer (ranitidine) sold under the brand names Atoma, Biomedic, Compliments, Exact, Life Brand, London Drugs, Option+, Personnelle, Pharmasave, Preferred Pharmacy, Rexall and Selection0224755175 mgAll lotsOctober 25, 2019
Pharmascience Inc.Maximum Strength Acid Reducer Without Prescription (ranitidine) sold under the brand names Atoma, Biomedic, Compliments, Co-op Care+, Equate, Exact, Health One, Kirkland Signature, London Drugs, Option+, Personnelle, Pharmasave, Rexall and Selection02293471150 mgAll lotsOctober 25, 2019
Pharmascience Inc.Acid Reducer (ranitidine) sold under the brand names Exact and Life Brand02400103150 mgAll lotsOctober 25, 2019
Pro Doc LimitéeRanitidine - 15000740748150 mgAll lotsSeptember 25, 2019
Pro Doc LimitéeRanitidine - 30000740756300 mgAll lotsSeptember 25, 2019
*NEW* Ranbaxy Pharmaceuticals Canada IncRan-Ranitidine02336480150 mgAll lotsOctober 30, 2019
*NEW* Ranbaxy Pharmaceuticals Canada IncRan-Ranitidine02336502300 mgAll lotsOctober 30, 2019
Sandoz CanadaSandoz Ranitidine02243229150 mgAll lotsSeptember 17, 2019
Sandoz CanadaSandoz Ranitidine02243230300 mgAll lotsSeptember 17, 2019
Sanis Health IncRanitidine02353016150 mgAll lotsSeptember 25, 2019
Sanis Health IncRanitidine02353024300 mgAll lotsSeptember 25, 2019
Sanofi Consumer Health Inc.Zantac (ranitidine)0223028775 mgAll lotsOctober 18, 2019
Sanofi Consumer Health Inc.Zantac Maximum Strength Non-Prescription (ranitidine)02277301150 mgAll lotsOctober 18, 2019
Sivem Pharmaceuticals ULCRanitidine02385953150 mgNP4179
NP4183
NP4184
NP5656
NP5657
NT2721
NT2722
NT2724
NT2757
NT2762
NT2763
NT2764
NT2765
PJ2434
PJ2435
PV6243
PV6244
PV6245
September 25, 2019
K46484
K46485
K48440
K48679
K50204
K50206
K50207
K50590
K50594
K50677
K50908
K50925
K50928
K50932
K50935
K51080
October 18, 2019
Sivem Pharmaceuticals ULCRanitidine02385961300 mgNP4177
NP4180
NT1365
PX8854
September 25, 2019
K50624
K50941
K50947
K50950
October 18, 2019
Teva Canada LimitedAct Ranitidine02248570150 mgAll lotsOctober 18, 2019
Teva Canada LimitedAct Ranitidine02248571300 mgAll lotsOctober 18, 2019
Vita Health Products Inc.Acid Reducer (ranitidine) sold under the brand names Equate, iPharma, Stanley and Western Family0229874075 mgAll lotsOctober 25, 2019
Vita Health Products Inc.Maximum Strength Acid Reducer (ranitidine) sold under the brand names Equate, iPharma and Western Family02298902150 mgAll lotsOctober 25, 2019

CONTACT US

Email : info@charneylawyers.com

Phone: 416-964-7950 ext: 223

Copyright © 2019 Ranitidine Class Action